Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic Medicine Without Borders: Which Strategies Should Developing Countries Employ to Invest in Precision Medicine? A New “Fast-Second Winner” Strategy

1 Nov 2017

Abstract excerpt

Genomic medicine has greatly matured in terms of its technical capabilities, but the diffusion of genomic innovations worldwide faces significant barriers beyond mere access to technology. New global development strategies are sorely needed for biotechnologies such as genomics and their applications toward precision medicine without borders. Moreover, diffusion of genomic medicine globally cannot adhere to a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biotechnology and Related Fields
Share to Genomics and Rare Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29140767
DOI: 10.1089/omi.2017.0141

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic Medicine Without Borders: Which Strategies Should Developing Countries Employ to Invest in Precision Medicine? A New “Fast-Second Winner” StrategyPMID 29140767Read ↗

Success stories in genomic medicine from resource-limited countriesSemantic proximity Read ↗

Translational Genomics in Low- and Middle-Income Countries: Opportunities and ChallengesSemantic proximity Read ↗

The expanding global genomics landscape: Converging priorities from national genomics programsSemantic proximity Read ↗

Optimizing regulatory frameworks for gene therapies in rare diseases: Challenges and solutionsSemantic proximity Read ↗

Quantifying hope: An EU perspective of rare disease therapeutic space and market dynamicsSemantic proximity Read ↗

Building an infrastructure to enable delivery of genomic medicineSemantic proximity Read ↗

Genomic medicine and developing countries: creating a room of their own.Semantic proximity Read ↗

Converging genetics, genomics and nanotechnologies for groundbreaking pathways in biomedicine and nanomedicineSemantic proximity Read ↗

Genomics, public health and developing countries: the case of the Mexican National Institute of Genomic Medicine (INMEGEN)Semantic proximity Read ↗

Global implementation of genomic medicine: We are not aloneSemantic proximity Read ↗

Patents and human genome research in developing countries: problems and proposals.Semantic proximity Read ↗

Unlocking sociocultural and community factors for the global adoption of genomic medicineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.